Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-TMEFF2 Antibody

Copy Product Info
🥰Excellent
Catalog No. T9901A-1352

Anti-TMEFF2 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human TMEFF2 protein (Tomoregulin-1) with exceptional binding affinity. It effectively facilitates the measurable detection of TMEFF2-positive malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads like Auristatin E (MMAE) during strictly monitored laboratory observation periods and molecular investigations to evaluate the disruption of prostate cancer progression.

Anti-TMEFF2 Antibody

Anti-TMEFF2 Antibody

Copy Product Info
🥰Excellent
Catalog No. T9901A-1352
Anti-TMEFF2 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human TMEFF2 protein (Tomoregulin-1) with exceptional binding affinity. It effectively facilitates the measurable detection of TMEFF2-positive malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads like Auristatin E (MMAE) during strictly monitored laboratory observation periods and molecular investigations to evaluate the disruption of prostate cancer progression.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-TMEFF2 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human TMEFF2 protein (Tomoregulin-1) with exceptional binding affinity. It effectively facilitates the measurable detection of TMEFF2-positive malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads like Auristatin E (MMAE) during strictly monitored laboratory observation periods and molecular investigations to evaluate the disruption of prostate cancer progression.
In vitro
In prostate cancer cell lines (LNCaP, C4-2B), Anti-TMEFF2 Antibody conjugates induced cell cycle arrest and apoptosis with IC50 values in the low nanomolar range [1].
In vivo
In human prostate cancer xenograft models (LuCaP 23.1, LuCaP 35), systemic administration of Anti-TMEFF2 Antibody conjugates significantly inhibited tumor growth and led to tumor regression [1].
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetTMEFF2
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-TMEFF2 Antibody | purchase Anti-TMEFF2 Antibody | Anti-TMEFF2 Antibody cost | order Anti-TMEFF2 Antibody | Anti-TMEFF2 Antibody in vivo | Anti-TMEFF2 Antibody in vitro